Skip to main content
Equibles

HighTower Advisors, LLC

Position in CRDF — Cardiff Oncology, Inc.

CIK 1462245 CHICAGO, IL
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$45,193
-$10,155 QoQ
Shares Held
34,764
+1.8% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 104 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. CRDF ranks #93 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 870,551 $82,484,707
2 REGN
Regeneron Pharmaceuticals, Inc.
 64,650 $40,311,861
3 ALNY
Alnylam Pharmaceuticals, Inc.
 105,045 $31,621,696
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 49,020 $24,349,704
5 RPRX
Royalty Pharma plc
 285,630 $16,015,274
6 EXEL
Exelixis, Inc.
 291,162 $15,842,124
7 AXSM
Axsome Therapeutics, Inc.
 56,313 $13,783,733
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 140,394 $11,443,514

All Filings in CRDF

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $45,193 34,764
2026-03-31 $55,348 34,166
2025-12-31 $96,118 34,206
2025-09-30 $70,464 34,206
2025-06-30 $107,748 34,206
2025-03-31 $107,428 34,213
2024-12-31 $148,484 34,213
2024-09-30 $40,939 15,333
2024-06-30 $35,597 16,035
2024-03-31 $96,120 18,000
2023-12-31 $22,692 15,333
2023-09-30 $21,312 15,333
2023-06-30 $22,539 15,333
2023-03-31 $25,299 15,333
2022-12-31 $21,466 15,333
2022-09-30 $23,612 15,333